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Abstract
Background and objectives: Sinus augmentation is a procedure used for augmenting
insufficient bone height that is often observed in the maxillary posterior areas. Many
different techniques as well as bone graft regimens have been suggested for performing
this procedure. It was the goal of this study to compare, clinically and histologically, two
different composite grafting regimens used for sinus augmentation.
Material and methods: Five patients, needing a bilateral sinus augmentation to allow
implant placement, were recruited for this study. Right sinuses were grafted with cortical
bone (collected from overlying the sinus membrane) and bovine hydroxyapatite (HA), while
the left side sinuses were grafted with overlying autologous bone plus a bioglass (BG)
material. Bone core biopsies were taken at 6 months after sinus graft or at the time of
implant insertion. A waiting period of 6 additional months was granted to allow healing,
before prosthetic restoration and functional loading. The level of peri-implant bone was
evaluated 12 months after loading. A comparative histomorphometric analysis was
conducted and a statistical analysis was performed.
Results: All implants in both groups were functional after a 12-month loading period. No
bone loss was observed radiographically or clinically in both groups. Histologic analysis
revealed that both composite grafts had a high biocompatibility. In the bovine HA-
containing group, minimal xenogenic graft absorption was noted. In contrast, BG group
samples presented a high absorption rate with some remaining particles imbedded in new
normal bone.
Conclusions: Sinus augmentation using a combination of autogenous bone plus either
bovine HA or BG is a predictable technique.
Sinus augmentation is a surgical approach
commonly used for the rehabilitation of the
posterior edentulous maxilla with dental
implants, when there is insufficient bone
height. The application of this surgical
approach allows clinicians to restore that
area, using implant-supported prosthesis
over implants of ideal dimensions. It has
been reported that the more the remaining
bone height, the higher the success rate
(Peleg et al. 1999). Similar results were also
reported by Jensen & Greer (1992). They
showed a 100% success rate if the remain-
ing bone from the floor of the sinus cavity
to the alveolar crest was  7 mm, vs.
29% if the residual bone height was
o3 mm. Nevertheless, the overall success
rate for the sinus augmentation has been
reported as more than 90% (Wallace &
Froum 2003). Currently, two major
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techniques are available to perform this
procedure: the use of osteotomes (Sum-
mers 1994) and a lateral window approach
(Tatum 1986). Many bone substitutes or
combination of grafts have been suggested
and tested with promising outcomes. Sev-
eral studies have shown that the healing
waiting periods after sinus augmentation
are largely dependent upon the type of bone
graft used (Froum et al. 2006), which may
also have a considerable impact in the
restorative timing.
A synthetic, resorbable, osteoconduc-
tive, alloplastic bioglass (BG), composed
by two different bioactive calcium phos-
phosilicate-like crystals (BG) has been
developed as a bone grafting material. The
major component of this material is a melt-
derived calcium phosphorus sodium sili-
cate, designed specifically for its absorb-
ability and osteoconductive nature. The
second component of this material is a
calcium–phosphorus silicate bioactive glass,
chemically similar to the major component,
but derived via a solution–gelation (sol–gel)
process. The sol–gel component allows
more quickly absorbed than the standard
melt-derived component (Wheeler et al.
2000), thus opening additional space be-
tween graft particles for tissue infiltration
and thereby replaced by host bone (Vogel
et al. 2001). This material is indicated in
filling bony voids or gaps, without affecting
the intrinsic stability of the osseous struc-
ture (Shapoff et al. 1997). However, so far
only limited research has been conducted
to test this material in sinus augmentation
procedures. Therefore, the purpose of this
study was to compare, clinically and his-
tologically, this newly developed synthetic
(BG) graft material to the commonly used




Five male patients, with a mean age of 62
(ranking from 45 to 78) were recruited for
the study after informed consent and
according to the principles of WHO
Declaration of Helsinki (Schuklenk &
Ashcroft 2000). All patients were partially
edentulous and in need of bilateral sinus
grafting for a future implant-supported
restoration. Subjects for the study were
selected according to the following inclu-
sion criteria: patients were systemically
healthy and did not take any drugs at least
2 weeks before the surgery, and had
o5 mm remaining alveolar bone height.
Smokers and patients suffering from any
disease known to alter bone metabolism
were excluded.
Surgical and restorative procedure
All the individuals were covered with
875/125 mg of amoxicillin/clavulanic
acid, one tab every 8 h 1 day before the
surgery. This medication was maintained
for 7 days. Patients received bilateral sinus
grafting during the same surgical proce-
dure. All surgical procedures were per-
formed under local anesthesia (Articain,
Ultracain; Aventis Inc., Frankfurt, Ger-
many). A modification of the conventional
lateral wall approach (Kaufman 2003) was
used to perform the sinus grafting in all
patients. A bone scraper was used to collect
autologous cortical bone and to expose the
Schneiderian membrane, following the
technique proposed by Galindo-Moreno
et al. (2007).
To avoid any selection bias, all right
sinus cavities were grafted with scraped
autogenous cortical bone (ACB) in combi-




AG, Wolhusen, Switzerland) in a 1 : 1 ratio.
Left sinus cavities received another compo-




Jacksonville, FL, USA) in a 1 : 1 ratio. After
bone grafting, an absorbable collagen mem-
brane (Bio-Gide
s
; Geistlich Pharma AG)
was placed over the lateral aspect of the
bony window to prevent soft tissue inva-
sion. Area was then carefully closed with
surgical silk 4/0 (Laboratorio Aragó, Barce-
lona, Spain). In all cases primary wound
closure was achieved.
After a 6-month healing period, a 3 mm
trephine was used to collect bone core
biopsies for future histologic analysis. The
samples were collected by means of an
osteotomy, in areas of planned implant
location, of 12 mm in depth from the
alveolar crest. All samples presented simi-
lar dimensions. A total of 28 implants
(TioBlast
s
, Astra Tech, Mölndal, Sweden)
were placed according to prosthetic treat-
ment plan. Implants were covered for
a two-stage surgical approach. After 6
months, they were surgically exposed for
prosthesis fabrication. Delivery of implant-
supported partial prosthesis took place 2
weeks after. The definitive restorations
were cemented and occlusal adjustment
performed. After implant loading, all
patients were included in a maintenance
program with 3 months recalls during the
first year then every 6 months during the
second year. Periapical radiographs of each
implant were taken at the day of implant
insertion, prosthesis delivery and 24
months after functional loading.
Radiographic peri-implant bone loss
assessment
Each periapical radiograph was digitalized
using a digital scanner. The mesial and
distal, peri-implant marginal bone loss
were obtained by subtracting baseline and
24 months after loading measurements
using the Digident Dent-A-View V 1.0
image analysis program as described by
Galindo-Moreno et al. (2005).
Histologic preparation
Bone core samples were immersed in buf-
fered 4%, pH 7.7 paraformaldehyde fixa-
tive for 5 days. After decalcified, during 8
days, in Decalcifier I compound by for-
maldehyde, formic acid and methanol
(Surgipath Europe Ltd, Peterborough,
UK), they were dehydrated in alcohol baths
of increasing concentrations, and em-
bedded in paraffin in an automatic tissue
processor (Shandon Pathcenter, Thermo-
Shandon, Pittsburgh, PA, USA). Subse-
quently, sections of 5mm wide were
obtained and placed on glass slides. The
histologic analysis was made on dewaxed
sections using the standard protocols for
hematoxylin–eosin (H–E) and Masson’s
trichrome stainings. All samples were ex-
amined under light microscopy (Micro-
photo FXA, Nikon, Tokyo, Japan), and
with polarized light.
Histomorphometric evaluation
For the analysis, the central portion of each
core was selected to avoid any potential
bias both the coronal (native host’s remain-
ing bone) and the apical portion (using a
safe margin of 1.5–2 mm) were excluded
from analysis. Histomorphometric mea-
surement of the samples was conducted
using Image J software, developed by the
National Institute of Health (NIH) of
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the United States of America. Values for
the total percentage of vital bone (VB),
remaining graft particle (RGP), and non-
mineralized connective tissue (CT) were
then calculated.
Statistical analysis
Data obtained from the histomorphometric
analysis were statistically analyzed using a
Wilcoxson’ signed-rank test. To show the
differences between groups, a P-value of
o0.05 was considered statistically signifi-
cant.
Results
Clinical and radiographic observations
No abnormal events were observed during
the total 12-month healing period. All
implants in both groups were functioning
24 months after loading. None of the
implants presented signs or symptoms of
inflammation or infection throughout the
study period. Radiographic assessment
revealed an average of 15.6 mm alveolar
height gain. Furthermore, no evidence of
bone loss around implants 2 years after
loading.
Histomorphometric analysis
At the time of bone core biopsies collec-
tion, a D2 bone density according to
Misch’s classification (Misch 1990) was
noted in the bovine HAþACB group,
while a D3–D4 bone quality was detected
in the sites treated with BGþACB.
Histologic examination revealed that
bovine HAþACB had a greater degree of
maturation compared with BGþACB.
However, bovine HA particles appeared to
be unaltered in their vast majority, with no
signs of remodeling. A great amount of
interposed non-mineralized CT and neoan-
giogenesis phenomena were observed.
After healing and bone maturation (bone
turnover), autogenous bone particles pre-
sent in the collected samples are indistin-
guishable in their majority from newly
formed or native bone, and cannot be easily
separated, both components having the
same origin. For this reason, it was decided
to quantify its totality as VB. Mean values
of 31.02 7.33% for VB, 17.28 1.32%
for remaining bovine HA particles and
51.68 7.21% for non-mineralized CT
(Table 1). Cellular morphology and distri-
bution around VB and bovine bone parti-
cles indicates that bone-remodeling events
are in line with an ideal bone turnover
(Fig. 1). No presence of inflammatory
infiltrate could be observed in any of the
samples, with irregular remaining bovine
HA distribution.
Table 2 showed mean values for remain-
ing alloplastic BG particle, VB and non-
mineralized CT were 14.15 6.8%,
33.08 8.18% and 53.35 4.24%, re-
spectively. Despite BG particles are
much smaller, their distribution within
the composite graft was less homo-
geneous than those found in the HA group
(Fig. 2). No inflammatory infiltrate was
observed.
No statistical significant differences
between the two groups were found
(Table 3).
Discussion
Several studies have reported that sinus
grafting techniques represent a predictable
and successful bone augmentation for im-
plant site development in the atrophic
posterior maxilla (Valentini et al. 1998).
Many techniques and biomaterials have
been tested, showing good results (Esposito
et al. 2006). Currently, autogenous bone is
thought to be the gold-standard material for
bone grafting techniques, including sinus
augmentation (Block et al. 1998), because
it possesses osteoconductive, osteoinduc-
tive, and osteogenic properties. These
beneficial properties emanate from its
structure and cellular/protein content
Table 1. Histomorphometric values for sinuses grafted with bovine hydroxyapatite (HA)
and autogenous bone collect from outside of lateral window by scrapper
Bovine HA Remaining particle (%) Vital bone (%) Connective tissue
J.C. 19.74 26.03 54.23
B.A. 16.62 19.98 63.39
J.A. 17.47 41.26 41.27
M.J. 15.87 33.75 50.38
A.C. 16.71 34.12 49.17
MEAN  SD 17.28  1.32 31.02  7.33 51.68  7.21
Fig. 1. Active osteoclasts arranged over a bovine hydroxyapatite particle surface (Masson’s trichrome  400).
Table 2. Histomorphometric values for sinuses grafted with synthetic alloplast and auto-
genous bone collect from outside of lateral window by scrapper
Bioglass Remaining particle (%) Vital bone (%) Connective tissue (%)
J.C. 26.78 21.51 51.7
B.A. 14.21 37.28 51.49
J.A. 6.53 45.98 47.49
M.J. 10.9 29.36 59.74
A.C. 12.35 31.32 56.33
Media  SD 14.15  6.8 33.08  8.18 53.35  4.24
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(Khan et al. 2000). Nevertheless, the need
for bone harvesting from another donor
sites may imply additional complications
to the patients as well as to the clinicians
(e.g., time, cost, skill and morbidity), in
addition to its limited quantity. Hence,
many alternative bone substitutes emerged
as an alternative to overcome these
deficiencies.
Results obtained from this study indi-
cated that the use of both, bovine HA and
synthetic BG, in combination of autoge-
nous particles is compatible with excellent
clinical outcomes, showing similar percen-
tages of VB, CT as well as residual graft
particles. This is in agreement with sys-
tematic reviews that have concluded that
bone-substitute materials are as effective
as autogenous bone when used alone or
in combination with autogenous bone, in
terms of survival and success rate for
implants placed after sinus grafting
(Wallace & Froum 2003; Del Fabbro et al.
2004). Similar findings were also reported
by Froum and collaborators. They showed
similar long-term outcomes when sinus
augmentation was performed with either
autologous bone alone or in combination
with bovine HA (Froum et al. 1998). Hall-
man and colleagues found that slightly
higher implant survival rates were asso-
ciated with the use of a purely bovine
HA graft (96%) vs. a composite graft
consisting of autologous bone and bovine
HA (94.4%) or autologous bone alone
(82.4%), 12-months after loading (Hallman
et al. 2002; Merkx et al. 2003). Merkx
and colleagues reported that addition of
autogenous bone provide a higher VB
proportion than that obtained when xeno-
genic substitutes are used exclusively
(Ulm et al. 1999; Galindo-Moreno et al.
2007).
Our group has advocated for a surgical
approach in which cortical bone is obtained
from the lateral wall of the sinus cavity via
scraped, then combined with an xenogenic
bone substitute (Olson et al. 2000). This
approach not only allows the clinician to
collect autologous bone to be used as part of
the grafting material, but also eliminates
the need for a second surgical site to
harvest autogenous bone.
Percentage of VB is an important para-
meter to be assessed in these type of stu-
dies. An average of 31–33% was found in
our sample. This is in accordance with
the results provided by Ulm and
colleagues in which a mean of 23% of
trabecular bone was identified (Thomas et
al. 2005). This could also explain the
higher success rates of implants inserted
in grafted sinuses compared with those
placed in pristine bone of the posterior
maxilla (Vrouwenvelder et al. 1993; Gatti
et al. 2006; Scarano et al. 2006).
The synthetic alloplastic BG material
used in this study primarily consists of a
mixture of two different types of
calcium phosphosilicate-like crystals.
This material is osteoconductive and
has a high absorption rate. It has a
Young’s modulus of 30–35 GPa, which is
close to that of cortical bone (Schlegel &
Donath 1998). This material has been
shown to accelerate osteogenic activity and
early alkaline phosphatase expression
in vitro. In addition, because it is
naturally resorbed, a subsequent release of
calcium and phosphate ions occurs,
which could stimulate osteoblast differentia-
tion (Gatti et al. 2006).
Although the data from our study failed
to show any statistical significant differ-
ence between ACBþHA and ACBþBG
for the parameters evaluated, it is
important to note that the clinical
bone density at the time of implant
placement was higher in the HA group.
This is further confirmed with the
histologic observation, where BG disorga-
nization was evident. This is unlike
to happen in the bovine HA specimen
where the remaining particles arrange-
ment was more homogeneous. Interest-
ingly, in some locations, remaining HA
particles started to be degraded, with
the presence of active osteoclasts on the
surface (Fig. 1). However, it is known
that absorption rate of bovine HA is very
low (Schlegel & Donath 1998), which
could explain that differential behavior
between samples.
Nevertheless, it can be finally conclu-
ded that both composite grafts are a
valid choice for sinus augmentation pro-
cedures.
Fig. 2. Histologic sample of ACBþBG group (  40 under polarized light). It can be observed newly formed
bone, containing collagen (stars). That is the reason why refringent parallel layers are present in the vital bone,
that contains ostecytes as well, vs. the bone substitute material remaining particles (BG), which do not present
protein content (pentagons). Also, note the remaining BG particles in relation with non-mineralized CT and
vital bone in absence of inflammatory infiltrate, which reflects its high biocompatibility.
Table 3. Wilcoxson signed ranks test (Po0.05 was considered statistically significant)







Statistical contrast Z  0.94  0.4  0.4
Statistical significance (P) 0.34 0.68 0.69
HA, hydroxyapatite.
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